Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Studies on the Noradrenaline α-Receptor

I. Techniques of Receptor Isolation. The Distribution and Specificity of Action of N-(2-Bromoethyl)-N-ethyl-1-naphthylmethylamine, a Competitive Antagonist of Noradrenaline

J. F. MORAN, M. MAY, H. KIMELBERG and D. J. TRIGGLE
Molecular Pharmacology January 1967, 3 (1) 15-27;
J. F. MORAN
Theoretical Biology Unit, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. MAY
Theoretical Biology Unit, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. KIMELBERG
Theoretical Biology Unit, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. J. TRIGGLE
Theoretical Biology Unit, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Studies have been made of the potential usefulness of adrenergic blocking 2-halogenoethylamines for labeling time α-receptor. The uptake of 3H-labeled N-(2-bromoethyl)-N-ethyl-N-1-naphthylmethylamine (3H-SY.28) by rabbit vas deferens was shown to be nonspecific and the 2-halogenoethylamine apparently showed little specificity for the α-receptor. In an attempt to obtain greater specificity, rabbit aorta and vas deferens were pretreated with N,N-dimethyl-2-bromo-2-phenylethylamine, a short-lasting irreversible α-receptor antagonist, prior to treatment with 3H-SY.28. Tissues pretreated with the short-lasting antagonist should take up less 3H-SY.28 and the difference between this uptake and that of controls should reflect the concentration of α-receptor material. However, this treatment did not afford any significant protection against the uptake of 3H-SY.28. The possible protective effects of various amines against labeling by 3H-SY.28 were also investigated: no correlation could be found between the protective ability of these amines and their "direct" or "indirect" sympathomimetic activities. An investigation was also made of the finding that trypsin can reverse the blockade of 3H-SY.28. It was concluded that the recovery of response following trypsin is probably unrelated to α-receptor regeneration.

The distribution of 3H-SY.28 and its corresponding alcohol was studied in rats. Our results suggest that the prolonged tissue retention of radioactivity following 3H-SY.28 is probably due to the high binding capacities of tissues for 3H-SY.28 alcohol rather than to the presence of high concentrations of covalently bound 3H-SY.28.

ACKNOWLEDGMENTS The authors wish to thank Miss Marlene Calderone for her technical assistance. This work was supported by Grant GM 11603 from the United States Public Health Service.

  • Copyright ©, 1967, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 3, Issue 1
1 Jan 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Studies on the Noradrenaline α-Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Studies on the Noradrenaline α-Receptor

J. F. MORAN, M. MAY, H. KIMELBERG and D. J. TRIGGLE
Molecular Pharmacology January 1, 1967, 3 (1) 15-27;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Studies on the Noradrenaline α-Receptor

J. F. MORAN, M. MAY, H. KIMELBERG and D. J. TRIGGLE
Molecular Pharmacology January 1, 1967, 3 (1) 15-27;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • EIPA, HMA and SMN2 gene regulation
  • Clc-2 has minor role in intestinal Cl- secretion
  • Resveratrol acts as an NR4A1 antagonist in lung cancer.
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics